Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATT vs CHOP in Intermediate Grade Lymphomas
NCT00002565Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 1994
- Primary completion
- Feb 2007
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of idarubicin, cisplatin, cytarabine, methylprednisolone, bleomycin in non-Hodgkin lymphoma (NHL), sponsored by University of Texas MD Anderson Cancer Center. Started May 1994; status: completed.
02
Drugs
idarubicincisplatincytarabinemethylprednisolonebleomycin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00002565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002565.